Catalyst Wire Dossier Catalyst Wire Dossier

RTGel-Based Botox Formulations

· UroGen Pharma Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RTGel-Based Botox Formulations, covering 2017-06-16 to 2017-06-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2") [Phase 1, Phase 2]

See pricing